Servier India launches biomarker testing initiative for AML and Cholangiocarcinoma patients EP News Bureau Nov 11, 2025 The programme is introduced in collaboration with MedGenome and Strand Life Sciences to expand access to molecular testing across…
Servier India launches IDH1-targeted therapy Ivosidenib for AML and Cholangiocarcinoma EP News Bureau Jun 5, 2025 CDSCO approves Servier’s Ivosidenib for treatment of AML and Cholangiocarcinoma patients with IDH1 mutation
